So lets see what we can all learn from this study, to understand how we can better use ketogenic interventions for metabolic and psychiatric care
She adds that when your provider presents obesity treatment as part of managing a long-term health condition and explains how the medication can improve blood sugar, cholesterol, and weight over time, it helps strengthen your case for medical necessity
Consider bringing: A brief symptom or side effect log Notes on appetite changes and average portion sizes Questions about dose timing or adjustments Your goals for the next phase of treatment These GLP-1 check-ins help ensure your plan continues to meet your needs safely and effectively
A denial doesnt mean you cant lose weight, just that semaglutide isnt appropriate for your situation
TD Cowen projects LLY captures roughly 62% of the $150 billion 2030 GLP-1 market
These trends are consistent with first-time prescribing rates seen around the holidays in previous years